Current opinions on therapeutic drug monitoring of immunosuppressive drugs
Open Access
- 31 October 1999
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (10), 1632-1652
- https://doi.org/10.1016/s0149-2918(99)80044-7
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the international neoral® tdm advisory consensus meeting (vancouver, november 1997)Transplantation Proceedings, 1998
- Therapeutic monitoring of mycophenolic acid: A consensus panel reportClinical Biochemistry, 1998
- Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acidClinical Biochemistry, 1998
- Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Consensus Guidelines for Therapeutic Drug Monitoring of Rapamycin: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Rapamycin: Distribution, Pharmacokinetics, and Therapeutic Range InvestigationsTherapeutic Drug Monitoring, 1995
- THE RELATIVE EFFECTS OF FK506 AND CYCLOSPORINE ON SHORT- AND LONG-TERM KIDNEY GRAFT SURVIVAL1,2,3Transplantation, 1995
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Consensus Document: Hawk's Cay Meeting on Therapeutic Drug Monitoring of CyclosporineClinical Chemistry, 1990
- Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring.Clinical Chemistry, 1987